Evidence map›Paper›PMID 31151170›Full record

ArticleInternational journal of molecular sciences2019

P3HT:Bebq

Chih-Chen Hsu, Yi-Ying Lin, Tien-Chun Yang, Aliaksandr A Yarmishyn, Tzu-Wei Lin, Yuh-Lih Chang, De-Kuang Hwang, Chien-Ying Wang, Yung-Yang Liu, Wen-Liang Lo and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Chih-Chen HsuDepartment of Ophthalmology, Taipei Veterans General Hospital, Taipei 11217, Taiwan. chihchienym@gmail.com.ORCID 0000-0003-2354-2999
Yi-Ying LinInstitute of Pharmacology, National Yang-Ming University, Taipei 11221, Taiwan. s19609005@gm.ym.edu.tw.
Tien-Chun YangDepartment of Medical Research, Taipei Veterans General Hospital, Taipei 11217, Taiwan. a8434040@hotmail.com.ORCID 0000-0003-3078-8276
Aliaksandr A YarmishynDepartment of Ophthalmology, Taipei Veterans General Hospital, Taipei 11217, Taiwan. yarmishyn@gmail.com.
Tzu-Wei LinDepartment of Ophthalmology, Taipei Veterans General Hospital, Taipei 11217, Taiwan. backyard0826@gmail.com.
Yuh-Lih ChangInstitute of Pharmacology, National Yang-Ming University, Taipei 11221, Taiwan. ylchang@vghtpe.gov.tw.
De-Kuang HwangDepartment of Ophthalmology, Taichung Veterans General Hospital, Taichung 40705, Taiwan. m95gbk@hotmail.com.ORCID 0000-0001-6346-8485
Chien-Ying WangSchool of Medicine, National Yang-Ming University, Taipei 11221, Taiwan. wangcy@vghtpe.gov.tw.
Yung-Yang LiuInstitute of Clinical Medicine, National Yang-Ming University, Taipei 11221, Taiwan. yyliu@vghtpe.gov.tw.
Wen-Liang LoInstitute of Oral Biology, National Yang-Ming University, Taipei 11211, Taiwan. wllo@vghtpe.gov.tw.
Chi-Hsien PengDepartment of Ophthalmology, Shin Kong Wu Ho-Su Memorial Hospital & Fu-Jen Catholic University, Taipei 11101, Taiwan. chpeng1008@gmail.com.
Shih-Jen ChenDepartment of Ophthalmology, Taipei Veterans General Hospital, Taipei 11217, Taiwan. sjchen96@gmail.com.
Yi-Ping YangDepartment of Medical Research, Taipei Veterans General Hospital, Taipei 11217, Taiwan. molly0103@gmail.com.
National Yang Ming Chiao Tung University · TWTaipei Veterans General Hospital · TWFu Jen Catholic University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Electric field stimulation is known to affect various cellular processes, including cell fate specification and differentiation, particularly towards neuronal lineages. This makes it a promising therapeutic strategy to stimulate regeneration of neuronal tissues. Retinal ganglion cells (RGCs) is a type of neural cells of the retina responsible for transduction of visual signals from the retina to the brain cortex, and is often degenerated in various blindness-causing retinal diseases. The organic photovoltaic materials such as poly-3-hexylthiophene (P3HT) can generate electric current upon illumination with light of the visible spectrum, and possesses several advantageous properties, including light weight, flexibility and high biocompatibility, which makes them a highly promising tool for electric stimulation of cells in vitro and in vivo. In this study, we tested the ability to generate photocurrent by several formulations of blend (bulk heterojunction) of P3HT (which is electron donor material) with several electron acceptor materials, including Alq3 and bis(10-hydroxybenzo[h]quinolinato)beryllium (Bebq2). We found that the photovoltaic device based on bulk heterojunction of P3HT with Bebq2 could generate photocurrent when illuminated by both green laser and visible spectrum light. We tested the growth and differentiation capacity of human induced pluripotent stem cells (hiPSC)-derived RGCs when grown in interface with such photostimulated device, and found that they were significantly increased. The application of P3HT:Bebq2-formulation of photovoltaic device has a great potential for developments in retinal transplantation, nerve repair and tissue engineering approaches of treatment of retinal degeneration.

Indexed as

Cell Culture TechniquesCell DifferentiationOrganoselenium CompoundsFluorescent Antibody TechniqueHumansInduced Pluripotent Stem CellsPolymersRetinal Ganglion CellsSpheroids, CellularOrganoselenium Compoundspoly(3-hexyl)selenophenePolymersinduced pluripotent stem cells (iPSC)photovoltaicpoly-3-hexylthiophene (P3HT)retinal ganglia cells (RGC)

Identifiers

PMID31151170
PMCPMC6600320
OpenAlexW2947405448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.